Efficacy and Treatment Outcomes of First-line Pazopanib Therapy in Advanced Renal Cell Carcinoma in Greece
These data demonstrate that pazopanib is well-tolerated and effective as first-line treatment in patients with favorable-intermediate risk metastatic RCC in real-life conditions in Greece.
Authors
- Michail Vaslamatzis
- Charisios Karanikiotis (ORCID: https://orcid.org/0000-0002-5229-7710)
- P. Makrantonakis
- E. Samantas
- Evangelos Bournakis
- Christos N. Papandreou
- Alexandros Ardavanis
- Ilias Athanasiadis (ORCID: https://orcid.org/0000-0001-5232-3862)
- Maria Michailidou
- Panagiotis Katsaounis (ORCID: https://orcid.org/0000-0003-3778-5705)
- Pavlos Papakotoulas
- Ioannis Xanthakis
- Christos Christodoulou (ORCID: https://orcid.org/0000-0002-8757-0596)
Institutions
- Theageneio General Hospital (GR)
- St. Luke's Hospital (GR)
- Papageorgiou General Hospital (GR)
- 424 General Military Hospital (GR)
- St Savas Hospital (GR)
- Mitera Hospital (GR)
- IASO General Hospital (GR)
- Metropolitan Hospital (GR)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-05-27
- DOI
- https://doi.org/10.21873/anticanres.17624
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52